Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Infect Dis. 2010 Feb;23(1):83-7. doi: 10.1097/QCO.0b013e328334de21.

Current concepts in managing pelvic inflammatory disease.

Author information

  • Department of Gynecology, Obstetrics & Reproduction, Maternite Regionale Universitaire of NANCY, Nancy, France. p.judlin@maternite.chu-nancy.fr

Abstract

PURPOSE OF REVIEW:

The management of pelvic inflammatory disease (PID) has significantly changed during the last two decades. Moreover, some recent bacterial findings have led to recent changes in this management.

RECENT FINDINGS:

Most cases of PID are mild-to-moderate uncomplicated forms that can be treated as outpatients. Apart from Chlamydia trachomatis and Neisseria gonorrhoeae, other pathogens such as Mycoplasma genitalium and bacterial vaginosis (BV)-associated bacteria are playing a significant role in PID and thus must be reckoned with. Moreover, gonococci have increasingly become resistant to the majority of antibiotics. This has led to a universal recommendation to treat N. gonorrhoeae infections with ceftriaxone. A few recent clinical trials have shown that quinolones and azithromycin (with metronidazole) are the best therapeutic options to treat uncomplicated PID.

SUMMARY:

The management of PID nowadays must take into account the role of pathogens such as M. genitalium, BV-associated bacteria and multiresistant gonococci.

PMID:
19935421
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk